IL263616B2
Antibody adjuvant conjugates
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both waysCites: the store holds 5 of 6
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US2012064593A1 | Cites | United States of America | XY | Search report | 1-6,11-12,29-30 |
| WO2015103987A1 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 1-6,11-12,29-30 |
| WO2015103989A1 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 1-6,11-12,29-30 |
| WO2015103990A1 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 1-6,11-12,29-30 |
| WO2018191746A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-30 |
| HOUZONG YAO ET AL:, METHODS TO DESIGN AND SYNTHESIZE ANTIBODY- DRUG CONJUGATES (ADCS), 2 February 2016 (2016-02-02) | Non-patent | – | – | Search report | – |
| ROBERT SCHWENK, ET AL., IGG2 ANTIBODIES AGAINST A CLINICAL GRADE PLASMODIUM FALCIPARUM CSP VACCINE ANTIGEN ASSOCIATE WITH PROTECTION AGAINST TRANSGENIC SPOROZOITE CHALLENGE IN MICE., 24 October 2014 (2014-10-24) | Non-patent | – | – | Search report | – |
55 members in 13 offices
Priority claims13
| Document | Office | Kind | Date |
|---|---|---|---|
| 201662359626 | United States of America | P | |
| 201662359627 | United States of America | P | |
| 62359626 | United States of America | – | |
| 62359627 | United States of America | – | |
| 201662432530 | United States of America | P | |
| 62432530 | United States of America | – | |
| 201662433742 | United States of America | P | |
| 62433742 | United States of America | – | |
| 201762522623 | United States of America | P | |
| 62522623 | United States of America | – | |
| 201762526306 | United States of America | P | |
| 62526306 | United States of America | – | |
| 2017041268 | United States of America | W |
Members55
| Document | Office | Kind | |
|---|---|---|---|
| US9302468B1 | United States of America | B1 | |
| EP3020553A1 | European Patent Office (EPO) | A1 | |
| WO2016077330A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2016200118A1 | United States of America | A1 | |
| US2016241744A1 | United States of America | A1 | |
| WO2017079069A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US9781307B2 | United States of America | B2 | |
| EP3247566A1 | European Patent Office (EPO) | A1 | |
| US2018007236A1 | United States of America | A1 | |
| EP3247566A4 | European Patent Office (EPO) | A4 | |
| US10075619B2 | United States of America | B2 | |
| US2019020787A1 | United States of America | A1 | |
| IL263616A | Israel | A | |
| US10419644B2 | United States of America | B2 | |
| US2020007716A1 | United States of America | A1 | |
| US10587777B2 | United States of America | B2 | |
| US2020169646A1 | United States of America | A1 | |
| US2020213473A1 | United States of America | A1 | |
| EP3247566B1 | European Patent Office (EPO) | B1 | |
| US10827097B2 | United States of America | B2 | |
| US10827098B2 | United States of America | B2 | |
| US2021067658A1 | United States of America | A1 | |
| US2021067658A1 | United States of America | A1 | |
| CA3150976A1 | Canada | A1 | |
| WO2021050118A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP3020553B1 | European Patent Office (EPO) | B1 | |
| ES2814273T3 | Spain | T3 | |
| ES2866749T3 | Spain | T3 | |
| AU2020345589A1 | Australia | A1 | |
| EP4028975A1 | European Patent Office (EPO) | A1 | |
| CN115317603A | China | A | |
| US11503187B2 | United States of America | B2 | |
| JP2022548054A | Japan | A | |
| US11547761B1 | United States of America | B1 | |
| EP3609540B1 | European Patent Office (EPO) | B1 | |
| PT3609540T | Portugal | T | |
| DK3609540T3 | Denmark | T3 | |
| PL3609540T3 | Poland | T3 | |
| US2023111340A1 | United States of America | A1 | |
| ES2939384T3 | Spain | T3 | |
| EP4028975A4 | European Patent Office (EPO) | A4 | |
| EP4218824A2 | European Patent Office (EPO) | A2 | |
| EP4218824A3 | European Patent Office (EPO) | A3 | |
| KR102590454B1 | Republic of Korea | B1 | |
| KR20230149857A | Republic of Korea | A | |
| JP2024001193A | Japan | A | |
| AU2017292934B2 | Australia | B2 | |
| EP3484518B1 | European Patent Office (EPO) | B1 | |
| EP3484518C0 | European Patent Office (EPO) | C0 | |
| AU2017292934B9 | Australia | B9 | |
| IL263616B1 | Israel | B1 | |
| DK3609540T5 | Denmark | T5 | |
| KR102726248B1 | Republic of Korea | B1 | |
| ES2990113T3 | Spain | T3 | |
| IL263616B2This record | Israel | B2 |
Numbers
- Publication
- 263616
- Application
- 263616
Titles2
- English
- ANTIBODY ADJUVANT CONJUGATES
- Hebrew
- מצמדי נוגדן–אג'ובאנט
Classification
- CPC, 32
- A61K47/6855
- A61K39/44
- A61K47/6801
- A61K47/6851
- A61K47/68
- A61K39/39
- A61K47/6849
- A61K39/3955
- C07K16/30
- A61K39/39558
- C07K16/28
- A61P35/00
- A61K2039/55511
- C07K2317/74
- C07K16/2887
- C07K16/3053
- C07K16/2818
- C07K16/2851
- C07K16/44
- C07K2317/52
- A61K2039/55561
- A61K2039/55572
- A61K2039/55516
- A61K2039/5555
- A61K47/55
- A61K47/6857
- A61K47/6803
- C07K16/2803
- C07K16/3061
- C07K16/32
- A61K2039/555
- C07K2317/24
- IPC, 3
- A61K47 68
- C07K16 28
- C07K16 30